Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

By afschroeder • July 8, 2025

Hashmi TM, Shafiq A, Zia R, Ashraf H, Burhan M, Ahmed M, Mesmar A, Ahmed R, Fonarow GC. Recombinant Human Pro-Urokinase vs. Alteplase Within 4.5 hours of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2025 Jul 5:108392. doi: 10.1016/j.jstrokecerebrovasdis.2025.108392. Epub ahead of print. PMID: 40623511.

Tags: alteplase, Cardiology/Epi, Publications, recombinant human pro-urokinase, stroke, thrombolytic therapy

Family History of Premature Atherosclerotic Cardiovascular Disease and Lipoprotein(a) Levels: A Multi Cohort Analysis

Razavi AC, Bhatia HS, Dardari ZA, Mehta A, Nasir K, Blankstein R, Isiadinso I, Quyyumi AA, Vaccarino V, Fialkow JA, Khoury MJ, Coronado F, Budoff[...]

Pulsed Field Ablation of Persistent Atrial Fibrillation With Continuous Electrocardiographic Monitoring Follow-Up: ADVANTAGE AF Phase 2

Reddy VY, Gerstenfeld EP, Schmidt B, Andrade JG, Nair D, Natale A, Saliba W, Sommer P, Metzner A, Verma A, Hounshell T, Amin A, Gentlesk[...]

Designing an Inclusive Onboarding Program for Academic Ambulatory Care Faculty

Bilek A, Rabbani A, Wampande J, Pregler J. Designing an Inclusive Onboarding Program for Academic Ambulatory Care Faculty. Cureus. 2025 Jun 4;17(6):e85356. doi: 10.7759/cureus.85356. PMID:[...]